By Healthcare Edge Editorial Staff Octave Bioscience, Inc. said Founder William Hagstrom will become Chairman of the Board, while Doug Biehn is the new President and CEO. Mr. Biehn has over 20 years of experience in healthcare, building and scaling growth businesses, the company, which treats neurodegenerative diseases, wrote in a statement. Before joining Octave, […]